SCHEMBL31074881

SCHEMBL31074881

CC(=O)CN1C(=O)CN(C[C@H](O)[C@H](O)[C@H](O)CO)c2[nH]c(=O)[nH]c(=O)c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31074849 0.90 — —
SCHEMBL31074858 0.89 — —
SCHEMBL31074847 0.89 — —
SCHEMBL31074888 0.89 — —
SCHEMBL31074840 0.89 — —
SCHEMBL31074792 0.89 — —
SCHEMBL31074844 0.88 — —
SCHEMBL31074891 0.87 MEN1 (0.30) —
SCHEMBL31074872 0.86 — —
SCHEMBL31074878 0.83 KDM4E (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024181466-A1 COMPOUND, MAIT CELL ACTIVATOR, VACCINE ADJUVANT, AND PHARMACEUTICAL COMPOSITION 国立大学法人京都大学 2024-09-06 — — WO disclosed
Send feedback